Medical News

RSS

International Association of Eating Disorders Professionals symposium to be held in Nevada

The International Association of Eating Disorders Professionals (iaedp) announces its 2013 Symposium slated for March 21-24 at the Westin Lake Las Vegas Resort and Spa in Henderson, Nevada. The program is celebrating its 27th year with five keynote speakers as headliners addressing innovative approaches to eating disorder treatment as well as thirty-two workshop presenters and preconference training sessions.

20 Nov 2012

Ventus Medical introduces Provent Sleep Apnea Therapy in Canada

Ventus Medical is pleased to announce the introduction of its proprietary Provent Sleep Apnea Therapy into Canada. Provent Therapy is an innovative, non-invasive treatment for obstructive sleep apnea (OSA).

20 Nov 2012

Public supports updating federal laws that require internet safety standards to protect kids

The Internet is full of information, but also full of real risks for children, like online predators or the pitfalls of losing privacy when kids share too much information. In a new University of Michigan poll, the majority of the public supports updating federal laws that require Internet safety standards to protect kids.

20 Nov 2012

New version of Optical Backscatter Reflectometer from Luna

Luna Innovations Incorporated today introduced a new version of its Optical Backscatter Reflectometer that's 200 times faster than competing solutions.

20 Nov 2012

Boston and Cincinnati Children's Hospital to learn more about how autism develops

A network of five leading medical centers, led by Cincinnati Children's Hospital Medical Center and Boston Children's Hospital, has received a five-year, $12.5 million National Institutes of Health (NIH) grant to learn more about how autism develops.

20 Nov 2012

CFFT announces major expansion of research collaboration with Pfizer

Cystic Fibrosis Foundation Therapeutics Inc. (CFFT), the nonprofit drug discovery and development affiliate of the Cystic Fibrosis Foundation, today announced a major expansion of its research collaboration with Pfizer Inc. designed to discover new drugs to treat people with the most common mutation of CF, Delta F508.

20 Nov 2012

Dune Medical Devices gets FDA PMA Approvable Letter for MarginProbe System

Dune Medical Devices, Inc., announced today that it has received an Approvable Letter for its Premarket Approval Application (PMA) from the Food and Drug Administration. The Approvable Letter states that the MarginProbe System PMA is approvable subject to final agreement with FDA on the design of the required Post Approval Study.

20 Nov 2012

Patheon to launch $30 million transferable rights offering

Patheon Inc., a leading provider of contract development and manufacturing services to the global pharmaceutical industry, today announced that it will launch a U.S. $30 million transferable rights offering.

19 Nov 2012

Diffusion Pharmaceuticals completes trans sodium crocetinate Phase I trial on glioblastoma

Diffusion Pharmaceuticals LLC, a biotechnology company developing innovative cancer treatments, today announced that it has successfully completed a Phase I clinical trial of its lead compound trans sodium crocetinate (TSC) in nine patients with newly diagnosed primary brain cancer (glioblastoma or GBM).

19 Nov 2012

FDA clears TomTec’s new Image-Com 5 software solution

TomTec Imaging Systems GmbH announces the FDA 510(k) clearance for its new Image-Com 5 software solution.

19 Nov 2012

Roundup: Wyo. conservatives ponder election; Ill. Insurer to buy Montana Blues; Calif. nurses plan new strike

But since the election, a blanket of baffled worry has descended on conservatives here like early snow across the plains, deepening a sense that traditional, rural and overwhelmingly white states in the center of the country are losing touch with an increasingly diverse and urban American electorate.

19 Nov 2012

Janssen receives positive opinion from EMA CHMP for ZYTIGA to treat mCRPC

Janssen-Cilag International NV (Janssen) announced today that the Committee for Medical Products for Human Use (CHMP) of the European Medicines Agency (EMA) has granted a positive opinion recommending approval of the oral, once-daily medication ZYTIGA for use in combination with prednisone or prednisolone in the treatment of metastatic castration-resistant prostate cancer (mCRPC), in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy and in whom chemotherapy is not yet clinically indicated.

19 Nov 2012

CCBC second quarter 2013 revenues increase 30.5% to RMB128.5 million

China Cord Blood Corporation, China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced its preliminary unaudited financial results for the second quarter and first half of fiscal year 2013, which ended September 30, 2012.

19 Nov 2012

Aetna, Glens Falls Hospital announce new multiyear agreement

Glens Falls Hospital and Aetna today announced a new multiyear agreement. Glens Falls will remain an "in-network" provider of care for Aetna members.

19 Nov 2012

GSK receives FDA approval for PROMACTA to treat thrombocytopenia

GlaxoSmithKline plc announced today that the U.S. Food and Drug Administration (FDA) has approved PROMACTA for the treatment of thrombocytopenia (low blood platelet counts) in patients with chronic hepatitis C to allow them to initiate and maintain interferon-based therapy.

19 Nov 2012

Ai Cure Technologies presents AiView digital health solution at CNS Summit

New York City-based Ai Cure Technologies opened the Innovation Showcase at CNS Summit in Boca Raton, Fla, with a presentation of its flagship digital health solution, AiView.

19 Nov 2012

New fiber-optic device can deliver light to the brain in 3D

A new tool for neuroscientists delivers a thousand pinpricks of light to a chunk of gray matter smaller than a sugar cube. The new fiber-optic device, created by biologists and engineers at the Massachusetts Institute of Technology (MIT) in Cambridge, is the first tool that can deliver precise points of light to a 3-D section of living brain tissue. The work is a step forward for a relatively new but promising technique that uses gene therapy to turn individual brain cells on and off with light.

19 Nov 2012

KemPharm announces successful Type B meeting with FDA for KP201

KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain, announced today a successful Type B meeting with the Food and Drug Administration (FDA) for its lead pain candidate, KP201.

19 Nov 2012

Altitude Organic introduces national caregiver management program in Arizona

Altitude Organic Corp, a subsidiary of Tranzbyte Corporation is pleased to announce it has launched its Altitude Organic national caregiver management program in Arizona.

19 Nov 2012

Viewpoints: 'Bad idea' about repealing Medicare cost board; Conservatives say health law repeal fight is not over

House Republicans like to talk about the need to find common ground with President Obama to make progress on important national issues, especially after the election. Yet within days, they were setting an agenda to eliminate an important element of his signature domestic achievement, the Affordable Care Act.

19 Nov 2012